B BIOVENTUS INC
| Market Cap | $554.57M |
| P/E Ratio | 51.75 |
| Forward P/E | 9.48 |
| Dividend Yield | — |
| Beta | 0.72 |
| 52W Range | $5.81 - $11.25 |
| # Hedge Funds | 0 |
| Sector | Healthcare |
| Industry | Medical Devices |
Hedge Fund Ownership
| Investor 0 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|
Insider Trading
| Insider Name of the company insider who made the trade 3 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| McMurry-Heath Michelle | Sale | 12,000 | $8.79 | $105.44K | 11 Mar 2026 | 13 Mar 2026 |
| NOHRA GUY P | Sale | 10,000 | $7.57 | $75.66K | 04 Dec 2025 | 08 Dec 2025 |
| McMurry-Heath Michelle | Sale | 17,701 | $7.42 | $131.25K | 07 Nov 2025 | 10 Nov 2025 |
Frequently Asked Questions
What is BVS stock price today?
BIOVENTUS INC (BVS) is currently trading at $8.28. The stock has a 52-week range of $5.81 to $11.25 and a market capitalization of $554.57M.
Is BVS a good stock to buy in 2026?
BIOVENTUS INC has a P/E ratio of 51.8 (forward P/E: 9.5), a dividend yield of none, and 1-year performance of -4.8%. 0 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling BVS stock?
There have been 3 insider transactions for BVS in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has BVS stock performed over the past year?
BIOVENTUS INC (BVS) has returned -4.8% over the past 12 months. The stock traded between $5.81 and $11.25 during this period, and is currently at $8.28.
Which hedge funds own BVS (BIOVENTUS INC)?
0 tracked hedge funds currently hold BVS in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is BVS's market cap and valuation?
BIOVENTUS INC (BVS) has a market capitalization of $554.57M. The trailing P/E ratio is 51.8 and forward P/E is 9.5. The stock is classified in the Healthcare sector.
What is BVS's revenue and profitability?
BIOVENTUS INC reported revenue of $568.09M with net income of $22.73M and a profit margin of 0.04%. The stock has a beta of 0.72.
What sector is BVS in and who are its biggest institutional holders?
BIOVENTUS INC (BVS) operates in the Healthcare sector. It is held by 0 tracked hedge funds. See the ownership table above for the complete list.